JPRN-UMIN000002041已完成1 期
A phase I trial of combination chemotherapy with docetaxel and 5-fluorouracil (DF) for advanced esophagogastric carcinoma (KDOG 0902 P1) - A phase I trial of combination chemotherapy with docetaxel and 5-fluorouracil (DF) for advanced esophagogastric carcinoma (KDOG 0902 P1)
Kitasato University School of Medicine0 个研究点目标入组 20 人开始时间: 2009年6月3日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Administration of the blood transfusion or G-CSF within 7 days before registration 2. History of serious drug hypersensitivity 3. Active infection 4. Watery diarrhea 5. Uncontrolled ileus 6. Active gastrointestinal bleeding 7. Severe pulmonary disease (interstitial pneumonia, pulmonary fibrosis, severe pulmonary emphysema or etc) 8. Symptomatic brain metastasis 9. Active synchronous or metachronous malignancy, excepting for esophageal and gastric carcinoma 10. Severe abnormality of ECG, severe heart disease (congestive heart failure, symptomatic ischemic heart disease, uncontrolled arrhythmia, history of myocardial infarction within 12 months, or etc) 11. Severe mental disorders, neurological disease 12. Pregnant or lactation women, or women with the possibility of the pregnancy and men who want let to pregnancy 13. Patients who are judged inappropriate for the entry into this study by the investigator
研究者
相似试验
已完成
1 期
A phase I study of the combination chemotherapy of IRISOX (irinotecan/S-1/oxaliplatin) in gemcitabine-refractory pancreatic cancergemcitabine-refractory pancreatic cancerJPRN-UMIN000022964Kitasato University School of Medicine12
已完成
1 期
Phase I-II study of combination chemotherapy with Irinotecan and Gemcitabine for clear cell or mucinous ovarian cancerClear cell or mucinous ovarian cancerJPRN-UMIN000005952Osaka university, faculty of medicine40
已完成
1 期
Phase I/II study of combination chemotherapy with Paclitaxel and TS-1 and Cisplatin for unresectable/ recurrent gastric cancerunresectable or recurrent gastric cancerJPRN-UMIN000004729School of Medicine, Keio University40
进行中（未招募）
不适用
.A phase ll trial of combination chemotherapy with intravenous oxaliplatin combined with tablet capecitabin in patients with recidivant breastcancerbreastcancer with metastasesMedDRA version: 16.0Level: PTClassification code 10006202Term: Breast cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2012-005329-56-DKDept of oncology50
招募中
1 期
Phase I/II trial of combination chemotherapy using TS-1, CPT-11 and cetuximab with radiation in locally advanced rectal cancerRectal cancerJPRN-UMIN000002602Yokohama City University Graduate School of Medicine35